Prevention of apomorphine- or cisplatin-induced emesis in the dog by a combination of methylnaltrexone and morphine

Cancer Chemotherapy and Pharmacology

Volumn 42, Issue 4, 1998, Pages 287-291

  Foss, Joseph F ^a   Yuan, Chun Su ^a   Roizen, Michael F ^a   Goldberg, Leon I ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Apmorphine; Chemotherapy induced emesis; Cisplatin; Methylnaltrexone; Morphine

Indexed keywords

17 METHYLNALTREXONE; APOMORPHINE; CISPLATIN; MORPHINE;

ANIMAL MODEL; ANTIEMETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DOG; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; VOMITING;

ADMINISTRATION, ORAL; ANIMALS; ANTIEMETICS; ANTINEOPLASTIC AGENTS; APOMORPHINE; CISPLATIN; DOGS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EMETICS; MALE; MORPHINE; NALTREXONE; NARCOTICS; QUATERNARY AMMONIUM COMPOUNDS; VOMITING;

EID: 0031826621     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050819     Document Type: Article

References (30)

1. Bakowski MT (1984) Advances in antiemetic therapy. Cancer Treat Rev 11: 237
2. Bhandri P, Gupta YK, Seth SD, Chugh A (1989) Cisplatin-induced emesis: effect of chemoreceptor trigger zone ablation in dogs. Asia Pac J Pharmacol 4: 209
3. Blancquaert JP, Lelebvre RA, Willems JL (1986) Emetic and antiemetic effects of opioids in the dog. Eur J Pharmacol 128: 143
4. Borison HL, McCarthy LE (1983) Neuropharmacology of chemotherapy-induced emesis. Drugs 25 [Suppl 1]: 8
5. Borison HL, Wang SC (1953) Physiology and pharmacology of vomiting. Pharmacol Rev 5: 193
6. Brown DR, Goldberg LI (1985) The use of quaternary narcotic antagonists in opiate research. Neuropharmacology 24: 181
7. Costello DJ, Borison HL (1977) Naloxone antagonizes narcotic self-blockade of emesis in the cat. J Pharmacol Exp Ther 203: 222
8. DiChiara G, Gessa GL (1978) Pharmacology and neurochemistry of apomorphine. Adv Pharmacol Chemother 15: 87
9. Foss JF, Orelind ER, Goldberg LI (1989) Methylnaltrexone is a peripheral antagonist of morphine-induced cough. Anesthesiology 71: A633
10. Foss JF, Bass AS, Goldberg LI (1993) Dose-related antagonism of the emetic effect of morphine by methylnaltrexone in dogs. J Clin Pharmacol 33: 747
11. Gylys JA, Doran KM, Buyniski JP (1979) Antagonism of cisplatin-induced emesis in the dog. Res Commun Chem Pathol Pharmacol 23: 61
12. Hasegawa S, Takeda N, Morita M, Horii A, Koiquka I, Kubo T, Matsunaga T (1992) Vestibular, central and gastral triggering of emesis. A study on individual susceptibility in rats. Acta Oto-laryngologica 112(6): 927
13. Janssen PA, Niemegeers CJE (1959) Chemistry and pharmacology of compounds related to 4-(4-hydroxy-4-phenyl-piperidino)-butyrophenone: Part II Inhibition of apomorphine vomiting in dogs. Arzneimittelforschung 9: 765
14. Kotake AN, Kuwahara SK, Burton E, McCoy CE, Goldberg LI (1989) Variations in demethylation of N-methylnaltrexone in mice, rats, dogs, and humans. Xenobiotica 19: 1247
15. Krueger H, Eddy N, Sumwalt M (1940) The pharmacology of the opium alkaloids. Public Health Rep S165: 704
16. McCarthy LE, Borison HL (1984) Cisplatin-induced vomiting eliminated by ablation of the area postrema in cats. Cancer Treat Rep 68: 401
17. Miller AD, Ruggiero (1994) Emetic reflex arc revealed by expression of the immediate-early gene c-fos in the cat. J Neurosci 14(2): 871
18. Naylor RJ, Rudd JA (1996) Mechanisms of chemotherapy, radiotherapy-induced emesis in animal models. Oncology 53 [Suppl 1]: 8
19. Rizzi CA, Sagrada A, Schiavone A, Schiantarelli P, Cesana R, Schiavi GB, Ladinsky H, Donetti A (1994) Gastroprokinetic properties of the benzimidazolone derivative BIMU 1, an agonist at 5-hydroxytryptamine4 and antagonist at 5-hydroxytryptamine3 receptors. Naunyn Schmiedebergs Arch Pharmacol 349(4): 338
20. Rowbotham MC, Joseph MS, Jones RT, Kei LC (1983) Failure of naloxone to reverse apomorphine effects in humans. Psychoneuroendocrinology 8: 95
21. Schurig JE, Florczyk AP, Rose WC, Bradner WT (1982) Antiemetic activity of butorphanol against cisplatin-induced emesis in ferrets and dogs. Cancer Treat Rep 66: 1831
22. Singh L, Field MJ, Hughes J, Kuo BS, Suman-Chauhan N, Tuladhar BR, Wright DS, Naylor RJ (1997) The tachykinin NK1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret. Eur J Pharmacol 321(2): 209
23. Tsukamoto G, Adachi A (1994) Neural responses of rat area postrema to stimuli producing nausea. J Auton Nerv Syst 49(1): 55
24. Wang SC, Glaviano VV (1954) Locus of emetic action of morphine and hydergine in dogs. J Pharmacol Exp Ther 111: 329
25. Wilson CWM, Brodie BB (1961) The absence of blood-brain barrier from certain areas of the central nervous system. J Pharmacol Exp Ther 133: 332
26. Wilson CWM, Murray AW, Titus E (1962) The effects of reserpine on uptake of epinephrine in brain and certain areas outside the blood-brain barrier. J Pharmacol Exp Ther 135: 11
27. Wislocki GB, King LS (1936) The permeability of the hypophysis and hypothalamus to vital dyes, with a study of the hypophyseal vascular supply. Am J Anat 58: 421
28. Wynn RL, Essien E, Thut PD (1993) The effects of different antiemetic agents on morphine-induced emesis in ferrets. Eur J Pharmacol 241(1): 47
29. Yuan CS, Barber WD (1993) Area postrema: gastric vagal input from proximal stomach and interactions with nucleus solitarius. Brain Res Bull 30: 119
30. Yuan CS, Foss JF, O'Connor M, Toledano A, Roizen MF, Moss J (1996) Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial. Clin Pharmacol Ther 59: 469